VARENICLINE TARTRATE

Post-LOE

varenicline tartrate

ANDAORALTABLET
Approved
Mar 2024
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
3

Clinical Trials (3)

NCT00743847Phase 2Withdrawn

A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia

Started Mar 2009
0
Schizophrenia
NCT00749944Phase 4Completed

Assessing Neuropsychiatric Symptoms Including Depression, Anxiety, Irritability, and Suicidal Thoughts or Behavior in Subjects Quitting Smoking on Varenicline Tartrate or Placebo

Started Sep 2008
110 enrolled
Smoking Cessation
NCT00371813Phase 3Completed

An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking

Started Sep 2006
334 enrolled
Smoking Cessation